Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 17 Oct 2024 | |
Neoplasms | Preclinical | US | 17 Oct 2024 | |
Neoplasms | Preclinical | PL | 17 Oct 2024 | |
Neoplasms | Preclinical | PL | 17 Oct 2024 |